As there is an urgent need for improved biomarkers to guide treatment decision making, we used a large primary HNSCC population-based cohort, including comprehensive follow-up data of patients, to investigate the association between TSPO expression and survival with clinicopathological parameters. The gene discussed is TSPO; the disease is head and neck squamous cell carcinoma.